These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3678595)

  • 41. Evaluation of passively absorbed saliva for determination of oral slow-release theophylline bioavailability in children.
    Vaughan LM; Milavetz G; Weinberger MM; Smith GD; Merrick JG
    Drug Intell Clin Pharm; 1988 Sep; 22(9):684-7. PubMed ID: 3215109
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A comparison of the pharmacokinetics of theophylline in asthmatic children in the acute episode and in remission.
    Arnold JD; Hill GN; Sansom LN
    Eur J Clin Pharmacol; 1981; 20(6):443-7. PubMed ID: 7286054
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A single-blind crossover study of two different slow release theophylline preparations.
    Tatsis G; Danos J; Gaga M; Pantelakis D; Veslemes M; Jordanoglou J
    J Int Med Res; 1988; 16(6):452-8. PubMed ID: 3069520
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Chronic asthma in children: comparison between a delayed-action theophylline preparation and a prompt-release aminophylline preparation].
    Longo G; Poli F; Strinati R; Longo F
    Pediatr Med Chir; 1984; 6(5):645-9. PubMed ID: 6535126
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Pharmacokinetics of a new slow-release theophylline preparation in asthmatic children].
    Nieto A; Mazón A; Caballero L; Gil MC
    An Esp Pediatr; 1985 Apr; 22(5):383-92. PubMed ID: 4014892
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics of theophylline and bioavailability of a sustained release theophylline preparation in patients with cystic fibrosis.
    Valet SB; Schwartz RH; Brooks JG
    Ann Allergy; 1983 Mar; 50(3):161-5. PubMed ID: 6829982
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma theophylline concentrations and airway function in asthmatic children receiving standard and modified RTC therapy.
    Arakawa H; Morikawa A; Shigeta M; Kato M; Kuroume T; Kimura T; Tateno K
    J Asthma; 1992; 29(4):235-43. PubMed ID: 1634448
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chronopharmacokinetics of theophylline after sustained release and intravenous administration to adults.
    Jonkman JH; van der Boon WJ; Balant LP; Schoenmaker R; Holtkamp A
    Eur J Clin Pharmacol; 1984; 26(2):215-22. PubMed ID: 6723760
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The consistency of theophylline absorption from a sustained-release formulation in asthmatic children.
    Hill M; Haltom JR; Szefler SJ
    Pharmacotherapy; 1988; 8(5):277-83. PubMed ID: 3255299
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sustained-release theophylline pharmacokinetics in the cat.
    Dye JA; McKiernan BC; Jones SD; Neff-Davis CA; Koritz GD
    J Vet Pharmacol Ther; 1989 Jun; 12(2):133-40. PubMed ID: 2746720
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Theophylline serum levels in children with bronchial asthma after administration of slow release theophylline as open or closed capsules.
    Naspitz CK; Solé D
    Respiration; 1989; 55(4):210-3. PubMed ID: 2595104
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Theophylline attenuates circulating vitamin B6 levels in children with asthma.
    Shimizu T; Maeda S; Mochizuki H; Tokuyama K; Morikawa A
    Pharmacology; 1994 Dec; 49(6):392-7. PubMed ID: 7878077
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The pharmacokinetics of a slow-release theophylline preparation in horses after intravenous and oral administration.
    Errecalde JO; Landoni MF
    Vet Res Commun; 1992; 16(2):131-8. PubMed ID: 1496815
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of a 12-hour sustained-release preparation in maintaining therapeutic serum theophylline levels in asthmatic children.
    Kelly HW; Murphy S
    Pediatrics; 1980 Jul; 66(1):97-102. PubMed ID: 7402798
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Steady-state pharmacokinetics and effects of a new once-daily, slow-release theophylline capsule preparation in asthma.
    Williams PE; Alwazir YA; Routledge PA; Campbell IA
    Br J Clin Pharmacol; 1986 Oct; 22(4):383-7. PubMed ID: 3768254
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum concentrations of theophylline in children following the administration of doses generally recommended: new dosage regimen required.
    Selvig K; Holmen TL; Aas K; Rugstad HE; Bjerve KS
    Acta Paediatr Scand; 1979 May; 68(3):435-9. PubMed ID: 443044
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Slow-release oral salbutamol and aminophylline in nocturnal asthma: relation of overnight changes in lung function and plasma drug levels.
    Fairfax AJ; McNabb WR; Davies HJ; Spiro SG
    Thorax; 1980 Jul; 35(7):526-30. PubMed ID: 7001670
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Pharmacokinetics and pharmacodynamics of sustained-release theophylline formulation, Slo-bid, in both single and multiple dosing studies of asthmatic children].
    Iwasaki E; Baba M
    Arerugi; 1989 Mar; 38(3):263-71. PubMed ID: 2751433
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bioavailability of a once daily-administered theophylline preparation. A comparison study.
    Mangura BT; Maniatis T; Abdel Rahman MS; Bartholf R; Lavietes MH
    Chest; 1986 Oct; 90(4):566-70. PubMed ID: 3757567
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sustained release theophylline in nocturnal asthma.
    Elias-Jones AC; Higenbottam TW; Barnes ND; Godden DJ
    Arch Dis Child; 1984 Dec; 59(12):1159-61. PubMed ID: 6395810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.